Serine
Serine is the smallest residue with a reactive side chain: a hydroxyl on a single carbon. It is a hydrogen bond donor, the commonest site of phosphorylation, and the nucleophile at the heart of a whole family of enzymes.
- Molecular formula
- C3H7NO3
- Molar mass
- 105.09 g/mol
- Residue mass, average
- 87.0782 Da
- Residue mass, monoisotopic
- 87.03203 Da
- pKa (α-COOH / α-NH₃⁺)
- 2.21 / 9.15
- Isoelectric point
- 5.68
- CAS number
- 56-45-1
Structure
- H
- C
- N
- O
- S
The 3D geometry represents the neutral experimental record; the pH control applies to the skeletal view.
The skeletal view begins with the zwitterion at pH 7.
A hydroxyl on a short arm
One methylene separates the −OH from the backbone, making serine compact and polar. It is close in size to alanine but behaves entirely differently because of that oxygen.
Weakly acidic, in practice not at all
The hydroxyl has a pKa around 13 in free solution, so it does not ionise in any normal buffer. Inside an enzyme active site, however, the local environment can lower that dramatically.
Charge and pH
Two steps
Serine titrates like alanine, with an isoelectric point of 5.68. The hydroxyl does not contribute in the accessible range.
Polarity without charge
Serine adds solubility and hydrogen bonding without adding charge, which makes it useful for improving the behaviour of a hydrophobic sequence.
Properties
| IUPAC name | (2S)-2-amino-3-hydroxypropanoic acid |
|---|---|
| Three-letter code | Ser |
| One-letter code | S |
| Class | Polar, uncharged |
| Dietary requirement | Non-essential |
| CAS | 56-45-1 |
| PubChem CID | 5951 |
| InChIKey | MTCFGRXMJLQNBG-REOHCLBHSA-N |
| Formula | C3H7NO3 |
|---|---|
| Molar mass | 105.09 g/mol |
| Residue mass, average | 87.0782 Da |
| Residue mass, monoisotopic | 87.03203 Da |
| Side chain | −CH₂OH |
| pKa, α-carboxyl | 2.21 |
| pKa, α-amino | 9.15 |
| Isoelectric point | 5.68 |
| Hydropathy | -0.8 |
| Volume ų | 73 |
Genetic code and occurrence
Codons
- UCU
- UCC
- UCA
- UCG
- AGU
- AGC
Codons are written as mRNA; U is uracil.
| Frequency in proteins | 6.63% |
|---|---|
| Number of codons | 6 |
| Dietary requirement | Non-essential |
Role in peptides
Phosphorylation
Serine is the most frequently phosphorylated residue in eukaryotic proteins. Each phosphate adds 79.97 Da and two negative charges, which is how a single modification can switch a protein’s behaviour.
The catalytic triad
In serine proteases such as trypsin and chymotrypsin, an activated serine attacks the peptide bond. The same triad appears in lipases and esterases.
The flexible linker
The Gly-Gly-Gly-Gly-Ser repeat is the standard linker in engineered fusion proteins. Glycine supplies flexibility and serine supplies the solubility that stops it sticking.
Biological role
Source of glycine and cysteine
Serine hydroxymethyltransferase converts serine to glycine, feeding one-carbon metabolism. Serine also supplies the carbon skeleton for cysteine.
Phospholipids and sphingolipids
Serine is the head group of phosphatidylserine and the starting point for sphingolipid synthesis. Phosphatidylserine appearing on the outer surface of a cell is the signal that marks it for clearance.
D-serine in the brain
D-serine, made by an enzyme that racemises the L form, is the main co-agonist at NMDA receptors in the forebrain, working alongside glycine. It is one of very few D-amino acids with an established role in mammals.
Non-essential, usually
Serine is made from a glycolytic intermediate and is normally plentiful, though some inherited disorders of serine synthesis cause severe neurological disease treated with supplementation.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| Serine synthesis disorders | In rare inherited defects of serine synthesis, supplementation is genuinely therapeutic. This is a defined medical use in a specific patient group. | Established in a rare disease |
| Sleep | A small randomised crossover trial reported that L-serine taken before bed improved subjective sleep quality, with a modest actigraphy signal. Numbers were small and the result needs independent replication. | Preliminary |
| ALS and neurological disease | L-serine has been trialled in amyotrophic lateral sclerosis and in a Guam neurodegenerative syndrome linked to an environmental toxin. Trials so far are early phase. | Early phase |
| Diabetic neuropathy | Serine supply has been proposed as relevant to a deoxysphingolipid pathway implicated in neuropathy. The work is largely preclinical. | Preclinical |
These summaries describe research on amino acids and related molecules, not evidence for Aminos products. Aminos products are laboratory research reagents, not supplements or medicines.
Laboratory notes
Beta-elimination at alkaline pH
Phosphoserine can undergo beta-elimination under strongly alkaline conditions, a reaction exploited in some analytical methods and avoided in others.
O-glycosylation site
Serine and threonine carry O-linked sugars, so recombinant material may show heterogeneity at those positions that synthetic material will not.
Easy synthesis
Serine needs a protecting group on the hydroxyl but otherwise couples without difficulty.
No UV signal
Serine contributes nothing at 280 nm.
References
Sources used for the data on this page.
- PubChem CID 5951: L-SerineIdentifiers, formula and physical data.
- pKa and pI values for the twenty amino acidsDepartment of Chemistry, University of Calgary.
Reference information only. This page describes the chemistry and biology of an amino acid. Nothing here is medical, nutritional or dosing advice. Aminos compounds are sold strictly for laboratory research use and are not medicines.